These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 9035421

  • 1. [Attempt at preventing hyperacute xenogenic rejection by isotopic suppression of IgM in the recipient].
    Pitre J, Kahan A, Fontaliran P, Houssin D, Weill B.
    Ann Chir; 1996; 50(7):524-31. PubMed ID: 9035421
    [Abstract] [Full Text] [Related]

  • 2. In vivo IgM depletion by anti-mu monoclonal antibody therapy. The role of IgM in hyperacute vascular rejection of discordant xenografts.
    Soares M, Lu X, Havaux X, Baranski A, Reding R, Latinne D, Daha M, Lambotte L, Bach FH, Bazin H.
    Transplantation; 1994 Apr 15; 57(7):1003-9. PubMed ID: 8165695
    [Abstract] [Full Text] [Related]

  • 3. Use of intravenous immunoglobulin to delay xenogeneic hyperacute rejection. An in vivo and in vitro evaluation.
    Gautreau C, Kojima T, Woimant G, Cardoso J, Devillier P, Houssin D.
    Transplantation; 1995 Nov 15; 60(9):903-7. PubMed ID: 7491691
    [Abstract] [Full Text] [Related]

  • 4. The role of natural IgM in the hyperacute rejection of discordant heart xenografts.
    Gambiez L, Salame E, Chereau C, Calmus Y, Cardoso J, Ayani E, Houssin D, Weill B.
    Transplantation; 1992 Oct 15; 54(4):577-83. PubMed ID: 1412747
    [Abstract] [Full Text] [Related]

  • 5. The effect of xenoreactive antibody and B cell depletion on hyperacute rejection of guinea pig-to-rat cardiac xenografts.
    Pruitt SK, Baldwin WM, Barth RN, Sanfilippo F.
    Transplantation; 1993 Dec 15; 56(6):1318-24. PubMed ID: 8278996
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Discordant heart xenografts in the rat. Additional effect of plasma exchange and cyclosporine, cyclophosphamide, or splenectomy in delaying hyperacute rejection.
    Van de Stadt J, Vendeville B, Weill B, Crougneau S, Michel A, Filipponi F, Icard P, Renoux M, Louvel A, Houssin D.
    Transplantation; 1988 Mar 15; 45(3):514-8. PubMed ID: 3279572
    [Abstract] [Full Text] [Related]

  • 8. FK778 in experimental xenotransplantation: a detailed analysis of drug efficacy.
    Schrepfer S, Deuse T, Koch-Nolte F, Krieger T, Haddad M, Schäfer H, Pelletier MP, Robbins RC, Reichenspurner H.
    J Heart Lung Transplant; 2007 Jan 15; 26(1):70-7. PubMed ID: 17234520
    [Abstract] [Full Text] [Related]

  • 9. Suppression of delayed xenograft rejection by specific depletion of elicited antibodies of the IgM isotype.
    Sato K, Takigami K, Miyatake T, Czismadia E, Latinne D, Bazin H, Bach FH, Soares MP.
    Transplantation; 1999 Sep 27; 68(6):844-54. PubMed ID: 10515386
    [Abstract] [Full Text] [Related]

  • 10. Modulation of acute and hyperacute rejection of xenografts in concordant hamster-to-rat combination.
    Sablinski T, Hancock WW, Wasowska BA, Schmidbauer G, Baldwin WM, Kut JP, Milford EL, Kupiec-Weglinski JW.
    Transplant Proc; 1993 Feb 27; 25(1 Pt 1):432-4. PubMed ID: 8438366
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation.
    Harrison PC, Mainolfi E, Madwed JB.
    J Heart Lung Transplant; 1998 Feb 27; 17(2):150-7. PubMed ID: 9513853
    [Abstract] [Full Text] [Related]

  • 15. The axis of interleukin 12 and gamma interferon regulates acute vascular xenogeneic rejection.
    Wang H, DeVries ME, Deng S, Khandaker MH, Pickering JG, Chow LH, Garcia B, Kelvin DJ, Zhong R.
    Nat Med; 2000 May 27; 6(5):549-55. PubMed ID: 10802711
    [Abstract] [Full Text] [Related]

  • 16. [Xenotransplantation: physiopathology of hyperacute and differentiated rejection, and therapeutic perspectives].
    Malassagne B, Calmus Y, Houssin D, Weill B.
    Pathol Biol (Paris); 2000 May 27; 48(4):377-82. PubMed ID: 10868402
    [Abstract] [Full Text] [Related]

  • 17. Effects of complement suppression on xenograft survival in hyperacute rejection.
    Mukai S, Orihashi K, Sueda T, Kajihara H, Matsuura Y.
    Hiroshima J Med Sci; 1999 Mar 27; 48(1):17-24. PubMed ID: 10213959
    [Abstract] [Full Text] [Related]

  • 18. Normal human polyclonal immunoglobulins for intravenous use significantly delay hyperacute xenograft rejection.
    Latremouille C, Haeffner-Cavaillon N, Goussef N, Mandet C, Hinglais N, Bruneval P, Bariety J, Carpentier A, Glotz D.
    Transplant Proc; 1994 Jun 27; 26(3):1285. PubMed ID: 8029910
    [No Abstract] [Full Text] [Related]

  • 19. [Superacute xenogenic rejection: attempted treatment with anti-idiotypic antibodies].
    Salamé E, Chereau C, Calmus Y, Ayani E, Houssin D, Weill B.
    Presse Med; 1992 Dec 02; 21(41):1945-6. PubMed ID: 1294946
    [Abstract] [Full Text] [Related]

  • 20. Delaying rejection in discordant heart xenografts in the rat: efficacy of cyclosporin, prostaglandin I2 and exchange transfusion.
    Meriggi F, Gigou M, Capron M, Houssin D, Forni E.
    Int Surg; 1990 Dec 02; 75(3):143-7. PubMed ID: 2242966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.